Research Article

Characteristics, Risk Factors, and Adverse Outcomes of Hyperkalemia in Acute-on-Chronic Liver Failure Patients

Table 1

Characteristics of all patients according to the presence of hyperkalemia.

variableswithout hyperkalemiaWith hyperkalemiaP-value
N=571N=79

Age (years)0.028
Male-n%436(76.4)65(82.3)0.241
Diabetes-n%104(18.2)15(19.0)0.868
Hypertension-n%74(13.0)13(16.5)0.392
Etiology of cirrhosis-n ()
Hepatitis B327(57.3)34(43.0)0.017
Alcoholic155(27.1)35(44.3)0.002
Hepatitis B plus alcoholic30(5.3)5(6.3) 0.896
Others59(10.3)5(6.3)0.263
Medications-n
Diuretic (frusemide/spironolactone)493(86.3)68(86.1)0.993
Potassium chloride263(46.1)33(41.8)0.473
Potassium citrate granules279(48.9)34(43.0)0.332
Beta-blockers37(6.5)5(6.3)0.959
Complications of cirrhosis-n
Ascites473(82.8)67(84.8)0.661
Bacterial infection458(80.2)74(93.7)0.004
Hepatic encephalopathy173(30.3)33(41.8)0.040
Acute kidney injury198(34.7)61(77.2)<0.001
Gastrointestinal bleeding111(19.4)28(35.4)0.001
Clinical and laboratory data at admission
MAP(mmHg)0.001
Heart rate(beats/minute)0.658
WBC(×109/L)<0.001
PLT(×109/L)78.0(51.0-123.5)98.5(48.0-130.0)0.589
ALB(g/L)0.026
TBIL(μmol/L )216.9(130.2-321.2)144.2(104.5-299.7)0.128
INR2.1(1.7-2.6)2.2(1.8-2.9)0.177
BUN(mmol/L)5.4(4.0-8.9)9.6(5.2-14.4)<0.001
Serum Cr(μmol/L)61.0(49.0-84.0)87.0(58.0-122.0)<0.001
Serum Na+ (mmol/L)134.1(130.3-137.1)131.3(125.1-135.6)<0.001
Serum K+ (mmol/L)3.9(3.4-4.3)4.7(3.7-5.5)<0.001
CTP score12.0(10.0-13.0)12.0(11.0-13.0)0.066
MELD score<0.001
CLIF-SOFA score7.0(6.0-8.0)7.0(7.0-11.0)0.002
Number of deaths-n%204(35.7)57(72.2)<0.001

MAP, mean arterial pressure; WBC, white blood cells; PLT, platelet; ALB, albumin; TBIL, total bilirubin; INR, international normalized ratio; BUN, blood uria nitrogen; Cr, creatinine; CTP, Child-Turcotte-Pugh; MELD, Model for End-Stage Liver Disease; CLIF-SOFA, chronic liver failure-sequential organ failure assessment.